CAS: 201605-51-8
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 1-Naphthalenepropanoic acid, β-[2-[[2-(8-azaspiro[4.5]dec-8-ylcarbonyl)-4,6-dimethylphenyl]amino]-2-oxoethyl]-, (βR)- REF: IN-DA002DJ5CAS: 201605-51-8 | - - - | A consultar | Mar 26 Nov 24 |
 | Itriglumide REF: TM-T27640CAS: 201605-51-8 | 99.95% | 272,00 €~1.836,00 € | Mar 14 Ene 25 |
![1-Naphthalenepropanoic acid, β-[2-[[2-(8-azaspiro[4.5]dec-8-ylcarbonyl)-4,6-dimethylphenyl]amino...](https://static.cymitquimica.com/products/IN/thumb/DA002DJ5.jpg)
1-Naphthalenepropanoic acid, β-[2-[[2-(8-azaspiro[4.5]dec-8-ylcarbonyl)-4,6-dimethylphenyl]amino]-2-oxoethyl]-, (βR)-
CAS:201605-51-8
Fórmula:
C33H38N2O4
Peso molecular:
526.6658
Ref: IN-DA002DJ5
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Martes 26 de Noviembre de 2024
Itriglumide
CAS:201605-51-8
Itriglumide, a CCK2 receptor antagonist, is used potentially for the treatment of peptic ulcers, dyspepsia, …
Fórmula:
C33H38N2O4
Pureza:
99.95%
Forma y color:
Solid
Peso molecular:
526.67
Ref: TM-T27640
| 1mg | 272,00 € | ||
| 2mg | 405,00 € | ||
| 5mg | 670,00 € | ||
| 10mg | 915,00 € | ||
| 25mg | 1.409,00 € | ||
| 50mg | 1.836,00 € |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025
